results of the zuma-1 trial exploring kte-c19 in nhl
Published 7 years ago • 58 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
2:24
zuma-1: a pivotal trial of axicabtagene ciloleucel (axi-cel; kte-c19) in patients with nhl
-
1:52
long-term results of zuma-1 trial for patients with nhl
-
1:13
dr. neelapu on primary results of the zuma-1 trial in nhl
-
2:02
discussing the results from the zuma-1 trial for patients with advanced lymphoma
-
2:03
long-term follow-up results from the zuma-1 trial in non-hodgkin lymphoma
-
1:04:53
nhl indolent & aggressive post ash 2024
-
29:00
dlbcl in 2023: top docs discuss the latest in diffuse large b-cell lymphoma | treatments & research
-
5:09
mytrialist clinical trial: epcore nhl-6
-
0:53
design of the zuma-1 trial in non-hodgkin lymphoma
-
2:00
long-term follow-up results of the zuma-1 trial of anti-cd19 car t-cells for non-hodgkin lymphoma
-
1:03
sattva neelapu, md, discusses the results of the zuma-1 pivotal phase 2 study with kte-c19
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma
-
3:41
interim results from the zuma-1 trial of novel car-t cells against non-hodgkin lymphoma
-
1:23
dr. locke on the zuma-i trial of kte-c19
-
4:19
the pivotal zuma-1 trial for nhl
-
1:50
dr. locke discusses long-term follow-up of zuma-1 trial for nhl
-
1:34
dr. neelapu on interim results of the phase ii zuma-1 study in dlbcl
-
4:52
long term follow up on the zuma-1 trial for nhl
-
0:46
key takeaway from 2-year follow-up data of zuma-1 trial in large b-cell lymphoma
-
1:35
an update on the epcore nhl-1 trial
-
8:01
high-risk lymphoma: the zuma-1 and scholar-1 trials
-
1:49
follow-up results of epcore nhl-1: subcutaneous epcoritamab in r/r lbcl